English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2358]
News [4933]
Articles [204]
Editorials [8]
Conferences [138]
elearning [14]
Density, benign disease raise risk of breast cancer
Density, benign disease raise risk of breast cancer
Benefits of PSA prostate cancer screening found to be more favourable than previous estimates, especially for blacks
Benefits of PSA prostate cancer screening found to be more favourable than previous estimates, especially for...
Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment
Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment
First mutation-targeted bladder cancer drug may be under-used
First mutation-targeted bladder cancer drug may be under-used
Immunotherapy after bladder cancer surgery shows excellent cancer-free survival rates
Immunotherapy after bladder cancer surgery shows excellent cancer-free survival rates
Study modeling tumour evolution reveals a vulnerability for cancer prevention and therapy
Study modeling tumour evolution reveals a vulnerability for cancer prevention and therapy
The combination makes the difference: New therapeutic approach against breast cancer
The combination makes the difference: New therapeutic approach against breast cancer
Gallstone disease shown to be a strong predictor of pancreatic cancer
Gallstone disease shown to be a strong predictor of pancreatic cancer
Starting screening before age 50 is found to significantly reduce the risk and incidence of colorectal cancer in women
Starting screening before age 50 is found to significantly reduce the risk and incidence of colorectal cancer in...
Ribociclib offers more life in the first-line setting for postmenopausal HR+/HER2- advanced breast cancer patients
Ribociclib offers more life in the first-line setting for postmenopausal HR+/HER2- advanced breast cancer patients
<1...132133134135136...494>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top